Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pluda

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A phase I study of pentosan polysulfate sodium in patients with advanced malignanciesR M Lush, W D Figg, J M Pluda, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medicationsN R Hartman, R Yarchoan, J M Pluda, et al.
Cancer Research|May 27, 1999
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repairT P Spiro, S L Gerson, L Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapyJ M Pluda, D J Venzon, G Tosato, et al.
Lancet (London, England)|July 1, 1995
Treatment of HIV-associated Kaposi's sarcoma with paclitaxelM W Saville, J Lietzau, J M Pluda, et al.
Annals of Internal Medicine|August 15, 1990
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapyJ M Pluda, R Yarchoan, E S Jaffe, et al.
Journal of the National Cancer Institute|May 15, 1991
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndromeM H Gail, J M Pluda, C S Rabkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcomaJ Bailey, J M Pluda, A Foli, et al.
Blood|August 1, 1990
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infectionJ M Pluda, R Yarchoan, P D Smith, et al.
Journal of the National Cancer Institute|October 6, 1993
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcomaJ M Pluda, L E Shay, A Foli, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A phase I study of pentosan polysulfate sodium in patients with advanced malignanciesR M Lush, W D Figg, J M Pluda, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medicationsN R Hartman, R Yarchoan, J M Pluda, et al.
Cancer Research|May 27, 1999
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repairT P Spiro, S L Gerson, L Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapyJ M Pluda, D J Venzon, G Tosato, et al.
Lancet (London, England)|July 1, 1995
Treatment of HIV-associated Kaposi's sarcoma with paclitaxelM W Saville, J Lietzau, J M Pluda, et al.
Annals of Internal Medicine|August 15, 1990
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapyJ M Pluda, R Yarchoan, E S Jaffe, et al.
Journal of the National Cancer Institute|May 15, 1991
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndromeM H Gail, J M Pluda, C S Rabkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcomaJ Bailey, J M Pluda, A Foli, et al.
Blood|August 1, 1990
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infectionJ M Pluda, R Yarchoan, P D Smith, et al.
Journal of the National Cancer Institute|October 6, 1993
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcomaJ M Pluda, L E Shay, A Foli, et al.
Pageof 6